Event JSON
{
"id": "173de9d3a15faf096e09d32fde6ba4574f3d3b2c876df90c613392c51a2fec2f",
"pubkey": "3699f5ef029cdd0f496952ed93f64bc30b5345ea3be51dff616b1d4da34b1f6c",
"created_at": 1741568387,
"kind": 1,
"tags": [
[
"imeta",
"url https://cdn.mastdn.ca/media_attachments/files/114/135/425/161/868/374/original/531c42ae25aa6013.jpeg",
"m image/jpeg",
"dim 1263x2000",
"blurhash U2A0?*~q00-=D%RixuayIUoffQj[IURjofay"
],
[
"imeta",
"url https://cdn.mastdn.ca/media_attachments/files/114/135/405/858/610/942/original/03647abb257c74a4.jpeg",
"m image/jpeg",
"dim 1382x408",
"blurhash UCRC*%NzD*RlMJM|R:a$?wnMbckC.mn$xsoc"
],
[
"imeta",
"url https://cdn.mastdn.ca/media_attachments/files/114/135/406/310/888/601/original/acf234341df65d39.jpeg",
"m image/jpeg",
"dim 1062x660",
"blurhash UGRC;_.7D%IU9FD$R%of_4D%WDxunUtTWCad"
],
[
"proxy",
"https://mstdn.ca/users/c_9/statuses/114135425810803216",
"activitypub"
]
],
"content": "Umm, this is big COVID vaccine news. Nobody tell RFK Jr.\n\nOriginal thread at link below.\n\nTHIS IS HUGE! Researchers at Stanford University have developed a dual-antibody treatment that remains effective against ALL SARS-CoV-2 variants by targeting a less-mutable part of the virus. This breakthrough could lead to longer-lasting therapies that OUTPACE viral evolution.\n\nThe study has been published in Science. YES, it is PEER-REVIEWED. https://www.science.org/doi/10.1126/scitranslmed.adq5720\n\n🧵 https://bsky.app/profile/sailorrooscout.bsky.social/post/3ljxftvw5x22h\n\nhttps://cdn.mastdn.ca/media_attachments/files/114/135/425/161/868/374/original/531c42ae25aa6013.jpeg\nhttps://cdn.mastdn.ca/media_attachments/files/114/135/405/858/610/942/original/03647abb257c74a4.jpeg\nhttps://cdn.mastdn.ca/media_attachments/files/114/135/406/310/888/601/original/acf234341df65d39.jpeg",
"sig": "39812849faa0ecaa7876c724edef09d5d5bfc7d6bb9a23a758b1771432f7a2af53e2ed864c20c9d010c53968a7c04d4d9dcc1d0e95a7d291c2ae515097643989"
}
